
### [MONDO:0019546](http://purl.obolibrary.org/obo/MONDO_0019546)
**Label:** other acquired skin disease

**Subclasses:** [MONDO:0018679](http://purl.obolibrary.org/obo/MONDO_0018679) (primary cutaneous plasmacytosis), [MONDO:0016379](http://purl.obolibrary.org/obo/MONDO_0016379) (erosive pustular dermatosis of the scalp), [MONDO:0018900](http://purl.obolibrary.org/obo/MONDO_0018900) (Corticosteroid-sensitive aseptic abscess syndrome), [MONDO:0016455](http://purl.obolibrary.org/obo/MONDO_0016455) (virus-associated trichodysplasia spinulosa), [MONDO:0015633](http://purl.obolibrary.org/obo/MONDO_0015633) (Bazex syndrome), [MONDO:0019975](http://purl.obolibrary.org/obo/MONDO_0019975) (pellagra), [MONDO:0019547](http://purl.obolibrary.org/obo/MONDO_0019547) (Wells syndrome), [MONDO:0017326](http://purl.obolibrary.org/obo/MONDO_0017326) (infective dermatitis associated with HTLV-1), [MONDO:0018139](http://purl.obolibrary.org/obo/MONDO_0018139) (scleredema), [MONDO:0017772](http://purl.obolibrary.org/obo/MONDO_0017772) (oral erosive lichen), [MONDO:0018302](http://purl.obolibrary.org/obo/MONDO_0018302) (acquired kinky hair syndrome), [MONDO:0019199](http://purl.obolibrary.org/obo/MONDO_0019199) (interstitial granulomatous dermatitis with arthritis), [MONDO:0018680](http://purl.obolibrary.org/obo/MONDO_0018680) (cutaneous pseudolymphoma), [MONDO:0015294](http://purl.obolibrary.org/obo/MONDO_0015294) (nephrogenic systemic fibrosis), [MONDO:0008436](http://purl.obolibrary.org/obo/MONDO_0008436) (Sneddon syndrome), [MONDO:0018051](http://purl.obolibrary.org/obo/MONDO_0018051) (Jessner lymphocytic infiltration of the skin), [MONDO:0006614](http://purl.obolibrary.org/obo/MONDO_0006614) (subcorneal pustular dermatosis), [MONDO:0018182](http://purl.obolibrary.org/obo/MONDO_0018182) (bullous impetigo), [MONDO:0011959](http://purl.obolibrary.org/obo/MONDO_0011959) (Sweet syndrome), [MONDO:0007313](http://purl.obolibrary.org/obo/MONDO_0007313) (cheilitis glandularis), [MONDO:0010146](http://purl.obolibrary.org/obo/MONDO_0010146) (Kerion celsi), 

**Mapped go classes:** [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity), [GO:0046103](http://purl.obolibrary.org/obo/GO_0046103) (inosine biosynthetic process), [GO:0043103](http://purl.obolibrary.org/obo/GO_0043103) (hypoxanthine salvage), [GO:0006154](http://purl.obolibrary.org/obo/GO_0006154) (adenosine catabolic process), [GO:0004000](http://purl.obolibrary.org/obo/GO_0004000) (adenosine deaminase activity), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0043394](http://purl.obolibrary.org/obo/GO_0043394) (proteoglycan binding), [GO:0060837](http://purl.obolibrary.org/obo/GO_0060837) (blood vessel endothelial cell differentiation), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0031685](http://purl.obolibrary.org/obo/GO_0031685) (adenosine receptor binding), [GO:0030223](http://purl.obolibrary.org/obo/GO_0030223) (neutrophil differentiation), [GO:0019239](http://purl.obolibrary.org/obo/GO_0019239) (deaminase activity), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- [GO:0046101](http://purl.obolibrary.org/obo/GO_0046101) (hypoxanthine biosynthetic process) 58.33%
- [GO:0043103](http://purl.obolibrary.org/obo/GO_0043103) (hypoxanthine salvage) 58.33%
- [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding) 58.33%
- [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity) 58.33%
- [GO:0006154](http://purl.obolibrary.org/obo/GO_0006154) (adenosine catabolic process) 58.33%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 58.33%
- [GO:0046100](http://purl.obolibrary.org/obo/GO_0046100) (hypoxanthine metabolic process) and [GO:1901576](http://purl.obolibrary.org/obo/GO_1901576) (organic substance biosynthetic process) 58.33%
- [GO:0046100](http://purl.obolibrary.org/obo/GO_0046100) (hypoxanthine metabolic process) and [GO:1901566](http://purl.obolibrary.org/obo/GO_1901566) (organonitrogen compound biosynthetic process) 58.33%
- [GO:0046100](http://purl.obolibrary.org/obo/GO_0046100) (hypoxanthine metabolic process) and [GO:1901362](http://purl.obolibrary.org/obo/GO_1901362) (organic cyclic compound biosynthetic process) 58.33%
- [GO:0046100](http://purl.obolibrary.org/obo/GO_0046100) (hypoxanthine metabolic process) and [GO:0072522](http://purl.obolibrary.org/obo/GO_0072522) (purine-containing compound biosynthetic process) 58.33%
- [GO:0046100](http://purl.obolibrary.org/obo/GO_0046100) (hypoxanthine metabolic process) and [GO:0046148](http://purl.obolibrary.org/obo/GO_0046148) (pigment biosynthetic process) 58.33%
- [GO:0046100](http://purl.obolibrary.org/obo/GO_0046100) (hypoxanthine metabolic process) and [GO:0046112](http://purl.obolibrary.org/obo/GO_0046112) (nucleobase biosynthetic process) 58.33%
- [GO:0046085](http://purl.obolibrary.org/obo/GO_0046085) (adenosine metabolic process) and [GO:1901658](http://purl.obolibrary.org/obo/GO_1901658) (glycosyl compound catabolic process) 58.33%
- [GO:0046085](http://purl.obolibrary.org/obo/GO_0046085) (adenosine metabolic process) and [GO:1901575](http://purl.obolibrary.org/obo/GO_1901575) (organic substance catabolic process) 58.33%
- [GO:0046085](http://purl.obolibrary.org/obo/GO_0046085) (adenosine metabolic process) and [GO:1901565](http://purl.obolibrary.org/obo/GO_1901565) (organonitrogen compound catabolic process) 58.33%


